ABSTRACT: Nonenzymatic glycation of lipids plays an important role in several physiological and pathological processes, such as normal aging and complications of diabetes mellitus. To develop liquid chromatography coupled with mass spectrometric (LC-MS) methods for accurate analysis of Amadori compound-glycated lipids from biological samples, it is essential to obtain isotope-labeled Amadori-lipid standards. Herein, we report optimized methods for the preparation of six stable isotope-labeled Amadori-glycated lipid standards covering four types of lipids, including [ 13 C 6 ]Amadori-phosphatidyl ethanolamine (PE), -phosphatidyl serine (PS), -LysoPE, and -LysoPS. Optimal conditions for the synthesis and purification of these four types of Amadori-glycated lipids were detailed in this study. LC-MS and LC-UV analyses showed that destination products were highly purified (>95%). Accurate mass and MS/MS fragmentation in both positive-and negative-ion modes further validated the identification of these six synthetic [ 13 C 6 ]Amadori-glycated lipid standards. Successful preparation of these highly purified isotope-labeled standards makes it possible to develop targeted LC-MS/MS methods for accurate analysis of Amadori-glycated phospholipids from biological samples.
INTRODUCTION
Nonenzymatic glycation, generally known as the Maillard reaction, is triggered by reaction of amino group in biomolecules and carbonyl function of reducing sugars (glucose, fructose, ribose, etc.) to form an unstable Schiff base, followed by the Amadori rearrangement reaction to form a more stable Amadori product. 1 Furthermore, Amadori compounds can undergo complex reactions to form advanced glycation end products (AGEs).
1 The Amadorimodified compounds and AGEs are implicated in the pathogenesis of age-related diseases and complications of mellitus.
1−4
The Maillard reaction of proteins and peptides has attracted the most attention in glycation and advanced glycation studies. 1 However, aminophospholipids are also important targets of nonenzymatic glycation.
3 For example, the nonenzymatic glycation of membrane lipids can cause peroxidation of proteins and membrane lipids, inactivation of receptors, and other membrane dysfunctions, which are involved in various physiological and pathological processes, such as aging, diabetes, atherogenesis.
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In vitro, Amadori products were reported with the ability to generate reactive oxygen species, which can further lead to lipid peroxidation involved in many physiological and pathological processes. 11 To better understand the roles of Amadori-glycated lipids in physiological and pathological processes, it is essential to develop analytical methods for a comprehensive profiling of Amadoriglycated lipid species in biological samples. To date, reported methods using liquid chromatography coupled with mass spectrometric (LC-MS) technique have focused on Amadoriphosphatidyl ethanolamine (PE) with a few identified molecular species. 12−14 For lipidomic level investigation on Amadoriglycated lipids, LC-MS/MS methods with high sensitivity should be developed for measuring various types of Amadori lipids. To this end, it is necessary to obtain stable isotope-labeled Amadori-glycated lipid standards with high purity.
Several preparation methods for Amadori-PE were already reported. However, these methods are not well suited for preparing stable-isotope-labeled standards, in that either a complex process of six steps is used 15, 16 or synthesis is carried out in methanol (MeOH) phosphate buffer (PB) medium, which requires a long reaction time (15 days) and a high amount of glucose (500 mM), 11, 17 the latter is prohibitive for isotopelabeled Amadori compound synthesis due to the high cost of [ 13 
MATERIALS AND METHODS
2.1. Chemical and Solvent. 1-Palmitoyl-2-oleoylsn-glycero-3-phosphoethanolamine (PE(16:0/18:1(9Z))), 1, 2-dipentadecanoyl-sn-glycero-3-phosphoethanolamine (PE-(15:0/15:0)), 1-tridecanoyl-sn-glycero-3-phosphoethanolamine (LysoPE(13:0)), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-Lserine (PS(16:0/18:1(9Z))), 1,2-diheptadecanoyl-sn-glycero-3-phospho-L-serine (PS(17:0/17:0)), and 1-tridecanoyl-sn-glycero-3-phospho-L-serine (LysoPS(13:0)) were purchased from Avanti Polar Lipids (Alabaster, AL). [U- 13 2.3.3. Phenylboronic Acid (PBA) SPE. Diol-containing Amadori-glycated lipids can bind to immobilized PBA, which enables isolation of Amadori-glycated lipids from their corresponding lipids. Bond Elut PBA cartridges (500 mg) purchased from Agilent (Palo Alto, CA) were adopted to perform SPE for cleanup. Briefly, PBA cartridges were wetted with 5 mL of MeOH and then conditioned with 3 mL of 150 mM ammonium formate (AF, pH 10), followed by 5 mL of 20% MeOH containing 100 mM AF (pH 8) (loading solvent). The dried resultant lipid extracts were redissolved in MeOH and diluted 10 times with loading solvent before loading onto equilibrated PBA cartridges. The cartridges were rinsed with 5 mL of MeOH containing 0.1% (v/v) ammonium hydroxide, then [ 13 C 6 ]Amadori-lipids were recovered by elution with 5 mL of 90% MeOH containing 1% formic acid. The elution effluent was nitrogen-dried and subjected to the following HPLC separation.
HPLC-UV Separation.
Semipreparative separation was performed on a Shimadzu 20A HPLC equipped with LC-8A pumps. The samples were loaded onto a Kromasil C 18 column (250 × 10 mm, 10 μm, AkzoNobel, Bohus, Sweden) using four isocratic mobile phases at a flow rate of 3 mL/min for different The TSQ Quantiva mass spectrometer was equipped with a heated electrospray ionization source, with positive-and negative-ion spray voltages set at 3500 and 3000 V, respectively. For both ionization modes, nitrogen was used as the sheath, auxiliary, and sweep gases at flow rates of 20, 7, and 1 (arbitrary units), respectively. Vaporizer and ion-transfer tube temperatures were 400 and 350°C, respectively. For MS analysis in full-scan mode, the scan range, scan rate, and resolution were m/z 200−1000, 1000 amu/s, and 0.7 (full width at half maximum), respectively. For MS/MS analysis in product ion scan mode, the argon collision gas pressure was 1.5 mTorr. The optimized collision energy was 20 eV for [ After incubation for 0, 1, 2, 3, and 4 days, aliquots of reaction mixtures were dried and then subjected to Folch extraction. CHCl 3 layer was transferred out, dried, reconstituted in MeOH, and then subjected to LC-MS analysis.
As shown in Figure 1 , reaction yield in complete MeOH medium was 3.2, 4.9, 5.8, and 7.0 times higher than those in MeOH-PB after incubation for 1, 2, 3, and 4 days, respectively. On the other hand, yields in MeOH were 1.3, 1.4, 1.3, and 1.4 times higher than those in MeOH + BHT after 1, 2, 3, and 4 days, respectively. BHT, a synthetic antioxidant that can effectively inhibit the browning reaction and lipid peroxidation, 17, 21, 22 was expected to prevent the formation of secondary byproducts and thus increase the recovery of destination product; however, our results showed that addition of BHT did not help the production of [ 13 C 6 ]Amadori-PE. In terms of effects of reaction temperature and time, as shown in Figure 2 , yields peaked at 60°C and 3 days for [ extraction, for which the Folch method was employed. Diolcontaining glucose has the ability to bind to immobilized PBA, 23 -PS(16:0/18:1(9Z)), and -PS(17:0/17:0) were pure (>95%), with purification process recoveries of about 43, 51, 31, and 25%, respectively. LC-UV chromatograms (Supporting Information Figure S1 ) also validated the high purity of [ ]-Amadori-LysoPS, besides its low recovery on PBA SPE, we found it was more unstable than the other species. To make the purification more efficient for [ 13 C 6 ]Amadori-LysoPS, direct purification using HPLC was employed, which utilizes isocratic elution with 75% MeOH containing 5 mM AF and 0.1% phosphoric acid. After HPLC preparation, phosphoric acid in the eluent was removed by C 18 SPE. [ 13 C 6 ]Amadori-LysoPS was recovered in MeOH, nitrogen-dried, and kept at −80°C. LC-MS full-scan chromatograms ( Figure 5 ) showed that [ 13 C 6 ]-Amadori-LysoPE(13:0/0:0)/LysoPS(13:0/0:0) were pure (>95%), with purification process recoveries of about 48 and 19%, respectively. LC-UV chromatograms (Supporting Information Figure S2 ) also validated their high purity.
The mass accuracy of the six purified [ 13 C 6 ]Amadori-lipids was confirmed by high-resolution mass spectrometry. A comparison between measured masses with calculated values exhibited a high mass accuracy (mass errors ranged from −2.6 to 2.4 ppm) (Supporting Information Table S1 ).
Isotopic purity of these six synthesized compounds was also investigated using high-mass-resolution LC-MS. Extracted ion chromatograms were generated and peak areas were integrated for each of the resolved isotopes related to these compounds (Supporting Information Figure S3 ). After subtracting the contribution from the non-fully labeled natural isotopes, peak area values of isotopes were used to calculate the relative percent of isotopic enrichment and the overall isotopic purity. As a result, these six synthesized compounds were found to be 93.67− 94.3% fully enriched (containing six labeled carbons); and the overall isotopic purities ranged from 98.9 to 99.0%, showing that 98.9−99.0% of the potentially labeled positions in these compounds were occupied by 13 C. This is in agreement with the 99% isotope purity of the starting material, [ Figures S4 and S5) . Next, product ion scanning was performed to investigate their fragmentation characteristics. In positiveion mode, neutral losses of 309. ]Amadori-PS/LysoPS, respectively, which were generated from the cleaved polar head groups ( Figure 6 ). It was notable that a neutral loss of 168.1 Da (isotope-labeled Amadori moiety, Furthermore, other characteristic ions related to fatty acyl chains of synthetic compounds and fragment ions of glycerophosphate groups could also be identified from the MS/MS negative spectra in Figure 7 . These characteristic ions are summarized in Table 2 , which are consistent with the fragmentation patterns of phospholipids previously reported. 27, 28 Representative fragmentation schemes of these synthetic Unlabeled analogues corresponding to these six [ 13 C 6 ]-labeled compounds were also synthesized and subjected to LC-MS/MS analysis. Each unlabeled analogue had the same retention time as its corresponding labeled compound under the same LC condition (Supporting Information, Figure S6) Figure S7 ). From their MS/MS spectra in negative-ion mode, the expected neutral loss of 162.1 Da (Amadori moiety) could also be observed for all of these six unlabeled compounds (Supporting Information Figure S8 ). Collectively, the expected fragmentation patterns and the corresponding mass shifts observed for all synthetic 
CONCLUSIONS
In this study, six stable isotope-labeled [ 13 C 6 ]Amadori-glycated lipids were synthesized, purified, and structurally confirmed using accurate mass measurement and tandem mass spectrometry, covering four types of lipids, including Amadori-PE, -PS, -LysoPE, and -LysoPS. Optimal conditions for the synthesis and purification of these four types of stable isotope-labeled Amadori-glycated lipids were obtained. MS/MS fragmentation in both positive-and negative-ion modes validated the identification of these novel synthetic compounds. The high purity (>95%) of these synthetic compounds was verified by both LC-MS full-scan analysis and LC-UV analysis. As a result, successful preparation of highly purified stable isotope-labeled Amadori-lipid standards makes it possible to develop targeted LC-MS/MS methods for accurate analysis of endogenous Amadori-glycated phospholipids from biological samples. 
